Want to see FR:IPH full AI Analyst Report?
Innate Pharma SA (IPH) Q2 2024 Earnings Report
FR:IPH Q2 2024 EPS Results
- Actual EPS
- -EUR 0.31
- Consensus EPS
- -EUR 0.28
- Beat/Miss
- Missed by -EUR 0.03
- One Year Ago EPS
- EUR 0.02
FR:IPH Q2 2024 Revenue Results
- Actual Revenue
- EUR 8.29M
- Expected Revenue
- EUR 12.40M
- Beat/Miss
- Missed by -EUR 4.11M
- YoY Revenue Growth
- -76.54%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 09/12/2024
- Time
- Before Open
- Conference Call
- Thursday, September 12, 2024
FR:IPH Upcoming Earnings
Innate Pharma SA's next earnings date is estimated for March 25, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
FR:IPH Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
FR:IPH Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 25, 2027 | 2026 (Q4) | -0.25- | -0.31 | ― | ― |
| Sep 17, 2026 | 2026 (Q2) | -0.16-0.21 | -0.25 | 16.00% (+0.04) | |
| Mar 26, 2026 | 2025 (Q4) | -0.12-0.31 | -0.31 | 0.00% (+0.00) | |
| Sep 17, 2025 | 2025 (Q2) | -0.28-0.25 | -0.31 | 19.35% (+0.06) | |
| Mar 27, 2025 | 2024 (Q4) | -0.26-0.31 | -0.12 | -158.33% (-0.19) | |
| Sep 12, 2024 | 2024 (Q2) | -0.28-0.31 | 0.02 | -1650.00% (-0.33) | |
| Mar 21, 2024 | 2023 (Q4) | -0.40-0.12 | -0.81 | 85.19% (+0.69) | |
| Sep 14, 2023 | 2023 (Q2) | 0.080.02 | 0.08 | -75.00% (-0.06) | |
| Mar 23, 2023 | 2022 (Q4) | -0.39-0.81 | -0.35 | -131.43% (-0.46) | |
| Sep 15, 2022 | 2022 (Q2) | 0.330.08 | -0.3 | 126.67% (+0.38) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
